RhumbLine Advisers’s Dianthus Therapeutics DNTH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $587K | Sell |
31,501
-3,544
| -10% | -$66K | ﹤0.01% | 2587 |
|
|
2025
Q1 | $636K | Sell |
35,045
-888
| -2% | -$16.1K | ﹤0.01% | 2410 |
|
|
2024
Q4 | $783K | Buy |
35,933
+1,316
| +4% | +$28.7K | ﹤0.01% | 2375 |
|
|
2024
Q3 | $948K | Buy |
34,617
+2,479
| +8% | +$67.9K | ﹤0.01% | 2287 |
|
|
2024
Q2 | $832K | Buy |
+32,138
| New | +$832K | ﹤0.01% | 2341 |
|
|
2022
Q2 | – | Sell |
-1,564
| Closed | -$73K | – | 3133 |
|
|
2022
Q1 | $73K | Buy |
1,564
+28
| +2% | +$1.31K | ﹤0.01% | 2940 |
|
|
2021
Q4 | $109K | Sell |
1,536
-11
| -0.7% | -$781 | ﹤0.01% | 2933 |
|
|
2021
Q3 | $180K | Sell |
1,547
-127
| -8% | -$14.8K | ﹤0.01% | 2925 |
|
|
2021
Q2 | $262K | Buy |
1,674
+128
| +8% | +$20K | ﹤0.01% | 2834 |
|
|
2021
Q1 | $293K | Sell |
1,546
-39
| -2% | -$7.39K | ﹤0.01% | 2702 |
|
|
2020
Q4 | $199K | Buy |
1,585
+335
| +27% | +$42.1K | ﹤0.01% | 2841 |
|
|
2020
Q3 | $136K | Sell |
1,250
-103
| -8% | -$11.2K | ﹤0.01% | 2802 |
|
|
2020
Q2 | $163K | Sell |
1,353
-20
| -1% | -$2.41K | ﹤0.01% | 2845 |
|
|
2020
Q1 | $138K | Hold |
1,373
| – | – | ﹤0.01% | 2701 |
|
|
2019
Q4 | $333K | Buy |
1,373
+12
| +0.9% | +$2.91K | ﹤0.01% | 2545 |
|
|
2019
Q3 | $223K | Sell |
1,361
-13
| -0.9% | -$2.13K | ﹤0.01% | 2708 |
|
|
2019
Q2 | $324K | Buy |
1,374
+415
| +43% | +$97.9K | ﹤0.01% | 2570 |
|
|
2019
Q1 | $253K | Buy |
+959
| New | +$253K | ﹤0.01% | 2630 |
|